Risk of secondary hematological malignancies and hematological toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance

Autor:	Myat Min Han, Sanjay Awasthi, Myet Mon Mon Zin, Catherine Jones, Fred Hardwicke, Rachana Yendala, Kyaw Zin Thein, Anita Sultan, Nicholas D'Cunha, Myo Zaw
Rok vydání:	2018
Předmět:	Oncology biology business.industry Recurrent Ovarian Cancer Poly ADP ribose polymerase biology.protein Poly Adenosine Diphosphate Ribose Cancer research Medicine Hematology business Polymerase
Zdroj:	Annals of Oncology. 29:viii343-viii344
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aa8d56aea74c0e3e867dfe7d708f9434 https://doi.org/10.1093/annonc/mdy285.169 Zobrazit plný text záznamu